Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 40, 2010 - Issue 3
554
Views
43
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Kinetic analysis of bile acid sulfation by stably expressed human sulfotransferase 2A1 (SULT2A1)

, , , , &
Pages 184-194 | Received 31 Oct 2009, Accepted 27 Nov 2009, Published online: 26 Jan 2010
 

Abstract

  1. Human sulfotransferase 2A1 (SULT2A1) is a member of the hydroxysteroid sulfotransferase (SULT2) family that mediates sulfo-conjugation of a variety of endogenous molecules including dehydroepiandrosterone (DHEA) and bile acids. In this study, we have constructed a stable cell line expressing SULT2A1 by transfection into HEK293 cells. The expression system was used to characterize and compare the sulfation kinetics of DHEA and 15 human bile acids by SULT2A1.

  2. Formation of DHEA sulfate demonstrated Michaelis–Menten kinetics with apparent Km and Vmax values of 3.8 μM and 130.8 pmol min−1 mg−1 protein, respectively. Sulfation kinetics of bile acids also demonstrated Michaelis–Menten kinetics with a marked variation in apparent Km and Vmax values between individual bile acids.

  3. Sulfation affinity was inversely proportional to the number of hydroxyl groups of bile acids. The monohydroxy- and most toxic bile acid (lithocholic acid) had the highest affinity, whereas the trihydroxy- and least toxic bile acid (cholic acid) had the lowest affinity to sulfation by SULT2A1. Intrinsic clearance (CLint) of ursodeoxycholic acid (UDCA) was approximately 1.5- and 9.0-fold higher than that of deoxycholic acid (DCA) and chenodeoxycholic acid (CDCA), respectively, despite the fact that all three are dihydroxy bile acids.

Acknowledgements

The authors would like to thank Dr Joseph Vetro and Dr Peng Zhang for excellent technical assistance, Dr Junichi Goto for his gifts of bile acid sulfate standards.

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.